ORCAS CEO, Michael Mulvihill, To Present At 2014 HERO Forum

ORCAS announced today that Michael Mulvihill, CEO, will present at the 2014 HERO (Health Enhancement Research Organization) Forum, which takes place Sept. 29 through Oct. 3 in San Diego.

Mulvihill will present on the topic of creating meaningful, results-driven, mobile behavior change interventions and the burgeoning role of technology in healthcare on Wednesday, October 1, 2014 at 3:00 pm to the more-than-400 employers, employee health management providers, industry professional organizations, and research experts who are expected to attend the HERO Forum.

“The HERO Forum attracts the top minds in employee health management and gives employers a platform to ask questions of noted experts, to share experiences with other employers, and to learn about the latest research and trends in employee wellness,” said Jerry Noyce, president and CEO of HERO. “We’re thrilled to have Michael Mulvihill on our esteemed lineup of presenters this year.”

Michael Mulvihill has 25 years in the wellness and behavioral health industry. He has transitioned ORCAS to a forward-thinking, customer driven company in a changing and complex market. Prior to his leadership role at ORCAS, Michael was the founder and past President and CEO at Leade Health, a pioneer of health coaching, founded in 1990 and sold to Ceridian in 2006.

Registration information and a complete agenda for the HERO Forum can be found online at www.the-hero.org, or by calling HERO at 952-835-4257.

About HERO – Based in Edina, Minn., HERO (the Health Enhancement Research Organization) is a non-profit corporation dedicated to the creation and dissemination of employee health management research, education, policy, strategy, and leadership. HERO was established in 1996 as a not-for-profit, 501(c)3 corporation to create high quality employee health management (EHM) research, especially that dealing with the impact of modifiable health risks on health care costs. To learn more, visit www.the-hero.org.  


Comments are closed.